Repros Therapeutics' IPO

Repros Therapeutics raised a round of funding on March 26, 1993. Investors include Public.

Repros Therapeutics, formerly Zonagen, focuses on the development of oral small molecule drugs for major unmet medical needs that treat male and female reproductive disorders.…

Articles about Repros Therapeutics' IPO: